Republic Services is at a record-setting $244.04, its second 52-week high in just over a week and 0.88% above the October 22 peak. The $74.8 billion waste hauler has added roughly $35 a share since late September.
Pfizer cleared $30 for the first time in a year, closing at $30.52 and topping its October 22 peak by 0.33%. The $173.9 billion drugmaker was trading near $23 twelve months ago.
Lucid carved out a fresh 52-week low at $3.02, 2.42% below the floor it set on October 19. The EV maker's market cap is down to $1.2 billion.
Lemonade just carved a new 52-week low at $42.94, 0.49% under the floor it set on Oct. 19. That leaves the insurtech down more than half from its $92.06 peak in January, with a $3.3 billion market cap.
A Q3 earnings beat pushed Imperial Oil to $138.10, a fresh 52-week high and 0.53% above the peak set on August 21. The $66.9 billion producer is now clearing the ceiling it has been testing since May.
Sponsored
A second 52-week low in a week at $23.95, 3.83% below the floor set on Oct. 23. The $9.7 billion miner traded above $76 inside the past year, so holders are watching support that no longer exists.
Chevron's Q3 earnings beat pushed it to a fresh 52-week high of $235.52, 0.99% above the record it set just a week ago. The $462 billion oil major keeps clearing its own ceiling.
Air Products just printed a new 52-week high at $316.43, clearing its early July peak by 0.71% and capping a climb off the $231 low set last December.
A new 52-week high at $276.07 for the insurance broker, 1.78% above the August 24 peak and a full recovery from May lows near $196. The $70.8 billion broker is back in price discovery.
Baidu set a new 52-week low at $76.40, 1.04% under the floor it just made on October 23. The search and AI giant is now a $21 billion company, less than half its January peak above $162.
Box notched a second straight 52-week high at $43.45, just 0.25% above yesterday's peak and nearly double the $21.82 low it sat at in late February. The $6.0 billion enterprise software name is now in uncharted territory for the year.
Sponsored
Jim Cramer publicly reversed course on Intel the morning after a quarter that actually beat Wall Street expectations, and his reason touches on a supply crisis that may run far longer than the company admits.
